Treprostinil Sodium

CAS 81846-19-7 6 API suppliersSmall Molecule

Overview

Treprostinil Sodium is a stable salt form of treprostinil, a synthetic analogue of prostacyclin, which acts as a potent vasodilator. It is primarily used for the treatment of pulmonary arterial hypertension to improve exercise ability and delay clinical worsening.

API suppliers (6)

Suppliers of Treprostinil Sodium evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India2Canada1Taiwan1Hungary1

Country recorded for 5 of 6 suppliers.

1 of 6 holds a GMP certificate on record in the EU or UK registers

Therapeutic areas

Cardiovascular DiseasesPulmonary Hypertension
Verified Supplier Partner

Do you supply Treprostinil Sodium? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.